Roy Galvin reports tax withholding on shares at Haemonetics
By AlphaYouPublished Form 4
Galvin Roy
Reporting filer
Roy Galvin reports tax withholding on shares, not an open-market purchase or sale, in Haemonetics Corp. Form 4 filed Nov 3, 2026 lists 1 entry.
- Disclosed
- Nov 3, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Galvin Roy | 2026-10-30 | F | Tax/exercise withholding | 146 | 119.65 | 39,805 | 4 days | Filed terms
|
Common Stock
- Owner
- Galvin Roy
- Date
- 2026-10-30
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 146
- Price
- 119.65
- Following holdings
- 39,805
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-30
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 146
- id: F1
- transaction Price Per Share: 119.65
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 39805
- id: F2
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Galvin Roy: EVP, Chief Commercial Officer.
- F1: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
- F2: This number includes unvested RSUs previously reported as well as 69 shares acquired by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time) on October 31, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.